<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10105">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02151305</url>
  </required_header>
  <id_info>
    <org_study_id>ROTEM_anesthesia</org_study_id>
    <nct_id>NCT02151305</nct_id>
  </id_info>
  <brief_title>Different Hemostasis According to the Anesthetic Agents</brief_title>
  <official_title>The Influence of Propofol and Sevoflurane on Hemostasis During Ophthalmic Surgery: Rotational Thromboelastographic Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      We investigated the hemostatic differences according to the main anesthetic agents by
      analyzing rotational thromboelastometry (ROTEM) under the hypothesis that propofol-based
      anesthesia would impair postoperative coagulability more than the sevoflurane-based
      anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Clotting time of ROTEM</measure>
    <time_frame>10 minutes before the induction of anesthesia, 1 h after finishing anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Clot firmness time of ROTEM</measure>
    <time_frame>10 minutes before the induction of anesthesia, 1 h after finishing anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Alpha angle of ROTEM</measure>
    <time_frame>10 minutes before the induction of anesthesia, 1 h after finishing anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum clot firmness of ROTEM</measure>
    <time_frame>10 minutes before the induction of anesthesia, 1 h after finishing anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematocrit</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet count</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International normalized ratio of prothrombin time</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activated partial thromboplastin time</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen</measure>
    <time_frame>10 minutes before the induction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Cataract</condition>
  <condition>Retina Detachment</condition>
  <condition>Pterygium</condition>
  <condition>Keratitis</condition>
  <condition>Vitreous Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Total intravenous anesthesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group received propofol and remifentanil for the maintenance of general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalation anesthesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group received sevoflurane for the maintenance of general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol, remifentanil</intervention_name>
    <arm_group_label>Total intravenous anesthesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <arm_group_label>Inhalation anesthesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patient scheduled for ophthalmic surgery under general anesthesia

          -  American Society of Anesthesiologist physical status I or II

        Exclusion Criteria:

          -  hematologic disorder

          -  severe anemia

          -  liver disease

          -  kidney disease

          -  taking a medication interfering with hemostasis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Seok Na</investigator_full_name>
    <investigator_title>Pf</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Keratitis</mesh_term>
    <mesh_term>Pterygium</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Vitreous Hemorrhage</mesh_term>
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
